Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report) traded up 1.1% during mid-day trading on Wednesday . The stock traded as high as $12.25 and last traded at $11.71. 46,028 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 109,689 shares. The stock had previously closed at $11.58.
Revolution Medicines Trading Up 2.1%
The firm has a fifty day moving average of $10.58 and a 200 day moving average of $6.60.
About Revolution Medicines
Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.
Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.
Featured Articles
- Five stocks we like better than Revolution Medicines
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Revolution Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolution Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
